COMP <GO>
BWAY vs NPCE // ALTMAN Z-SCORE & DEBT/EQUITY
BrainsWay Ltd. (NASDAQ) VS. Neuropace Inc. (NASDAQ) • 15-METRIC TALLY: BWAY 2
— NPCE 0
■ METRIC PARITY
LAST: $11.09 (-2.38%) • MKT CAP: $455.9M
balance-sheet
—
LAST: $12.34 (+0.33%) • MKT CAP: $422.2M
balance-sheet
0.20
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BWAY VS. NPCE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BWAY | NPCE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 77.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -23.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -2.54% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -16.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -21.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 25.10% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 5/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.6 | 41.7 | +0.90 | BWAY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $455.9M | $422.2M | $33.7M | BWAY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BWAY REV | NPCE REV | BWAY GROSS % | NPCE GROSS % | BWAY FCF | NPCE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $100.0M | — | 77.2% | — | -$11.3M |
| FY 2024 | — | $79.9M | — | 73.9% | — | -$18.3M |
| FY 2023 | — | $65.4M | — | — | — | -$19.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BWAY // BETA —
NPCE // BETA —